Literature DB >> 15670919

Ngamma-aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site.

C Sean Esslinger1, Kimberly A Cybulski, Joseph F Rhoderick.   

Abstract

Analogues of L-glutamine were designed and synthesized to test a hydrogen-bond hypothesis between ligand and neutral amino acid transporter ASCT2. The key design feature contains a substituted phenyl ring on the amide nitrogen that contains electron withdrawing and electron donating groups that alter the pKa of the amide NH. Through this study a preliminary binding site map has been developed, and a potent commercially available competitive inhibitor of the ASCT2 transporter has been identified.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15670919     DOI: 10.1016/j.bmc.2004.11.028

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  55 in total

1.  Bidirectional transport of amino acids regulates mTOR and autophagy.

Authors:  Paul Nicklin; Philip Bergman; Bailin Zhang; Ellen Triantafellow; Henry Wang; Beat Nyfeler; Haidi Yang; Marc Hild; Charles Kung; Christopher Wilson; Vic E Myer; Jeffrey P MacKeigan; Jeffrey A Porter; Y Karen Wang; Lewis C Cantley; Peter M Finan; Leon O Murphy
Journal:  Cell       Date:  2009-02-06       Impact factor: 41.582

2.  Supramolecular Probes for Assessing Glutamine Uptake Enable Semi-Quantitative Metabolic Models in Single Cells.

Authors:  Min Xue; Wei Wei; Yapeng Su; Dazy Johnson; James R Heath
Journal:  J Am Chem Soc       Date:  2016-02-26       Impact factor: 15.419

3.  2-Amino-4-bis(aryloxybenzyl)aminobutanoic acids: A novel scaffold for inhibition of ASCT2-mediated glutamine transport.

Authors:  Michael L Schulte; Alexandra B Khodadadi; Madison L Cuthbertson; Jarrod A Smith; H Charles Manning
Journal:  Bioorg Med Chem Lett       Date:  2015-12-11       Impact factor: 2.823

4.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 5.  Targeting Metabolic Cross Talk between Cancer Cells and Cancer-Associated Fibroblasts.

Authors:  Jin G Jung; Anne Le
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 6.  From Krebs to clinic: glutamine metabolism to cancer therapy.

Authors:  Brian J Altman; Zachary E Stine; Chi V Dang
Journal:  Nat Rev Cancer       Date:  2016-07-29       Impact factor: 60.716

7.  1,25-Dihydroxyvitamin D inhibits glutamine metabolism in Harvey-ras transformed MCF10A human breast epithelial cell.

Authors:  Xuanzhu Zhou; Wei Zheng; G A Nagana Gowda; Daniel Raftery; Shawn S Donkin; Brian Bequette; Dorothy Teegarden
Journal:  J Steroid Biochem Mol Biol       Date:  2016-05-03       Impact factor: 4.292

8.  Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine.

Authors:  Tristan Baguet; Jeroen Verhoeven; Glenn Pauwelyn; Jiyun Hu; Patricia Lambe; Stef De Lombaerde; Sarah Piron; Sam Donche; Benedicte Descamps; Ingeborg Goethals; Christian Vanhove; Filip De Vos; M Hassan Beyzavi
Journal:  Nucl Med Biol       Date:  2020-04-03       Impact factor: 2.408

Review 9.  Therapeutic strategies impacting cancer cell glutamine metabolism.

Authors:  Michael J Lukey; Kristin F Wilson; Richard A Cerione
Journal:  Future Med Chem       Date:  2013-09       Impact factor: 3.808

10.  SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival.

Authors:  Mohamed Hassanein; Megan D Hoeksema; Masakazu Shiota; Jun Qian; Bradford K Harris; Heidi Chen; Jonathan E Clark; William E Alborn; Rosana Eisenberg; Pierre P Massion
Journal:  Clin Cancer Res       Date:  2012-12-04       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.